Latest rheumatoid arthritis Stories
With a new therapeutic product, researchers have managed to cure arthritis in mice for the first time.
BMI analysis shows high efficacy of CF101; The data supports the design of the forthcoming Phase III clinical studies PETACH TIKVA, Israel, Aug.
Supports progression of this first-in-class anti-TLR4 monoclonal antibody into clinical proof of concept study as a potential personalized medicine for rheumatoid arthritis GENEVA, August
DUBLIN, July 28, 2014 /PRNewswire/ -- Research and Markets has announced the
Annual conference provides groundbreaking approaches to treating patients with interrelated autoimmune conditions. Malvern, PA (PRWEB) July 18, 2014
PORTLAND, Ore., July 16, 2014 /PRNewswire-USNewswire/ -- Thirteen scientists received a total of $1.05 million in funding from the National Psoriasis Foundation for projects that aim to identify new
In this webinar, the presenters will discuss how to leverage time response modeling to optimize clinical trial design and better predict trial outcomes for Rheumatoid Arthritis (RA) and similar
Paddison Program For Rheumatoid Arthritis is a new product created by Clint Paddison and is aimed at helping people treat their rheumatoid arthritis by curing it for good.
Australian researchers reveal that sudden, acute episodes of low back pain are not linked to weather conditions such as temperature, humidity, air pressure, wind direction and precipitation.
- A transitional zone between two communities containing the characteristic species of each.